Impact of Prediabetes and Type-2 Diabetes on Outcomes in Patients with COVID-19.

Jasbir Makker Haozhe Sun Harish K Patel Nikhitha Mantri Maleeha Zahid Sudharsan R Gongati Sneha Galiveeti Sharon W Renner Sridhar Chilimuri

Published in: International journal of endocrinology (2021)

In older patients aged 55 years and above, status of type-2 diabetes does not influence their mortality. However, in younger patients aged less than 55 years, the presence of type-2 diabetes is an important driver of mortality. Newly diagnosed type-2 diabetes, in comparison with previously diagnosed type-2 diabetes, may have better survival. Presence of prediabetes did not affect outcomes in patients with COVID-19 infection.

Keyphrases

type diabetes
newly diagnosed
glycemic control
cardiovascular disease
insulin resistance
end stage renal disease
cardiovascular events
ejection fraction
chronic kidney disease
risk factors
prognostic factors